单细胞分析市场－全球产业规模、份额、趋势、机会和预测，按产品、技术、细胞类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球单细胞分析市场价值为 39.8 亿美元，预计到 2030 年将达到 72.1 亿美元，复合年增长率为 10.41%。该市场代表了生物医学创新的前沿，能够对基因组学、肿瘤学、免疫学和神经病学等各个学科的单一细胞进行高解析度的询问。个人化医疗需求的不断增长是一个主要的成长动力，因为研究人员和临床医生采用单细胞技术为个别患者量身定制治疗方案，提高治疗效果并降低成本。在细胞层面上表征肿瘤异质性的能力极大地促进了癌症研究和诊断。此外，单细胞 RNA 定序和高通量成像等创新正在扩展分析能力，推动其在药物开发和疾病研究中的应用。随着投资激增和应用范围扩大，单细胞分析正在发展成为生命科学领域的变革工具，加速发现并促进全球精准医疗的进步。

关键市场驱动因素

癌症盛行率上升推动市场

主要市场挑战

数据复杂度与解释

主要市场趋势

多组学整合

目录

第一章：服务概述

• 市场定义
• 市场范围
  • 覆盖市场
  • 考虑学习的年限
  • 主要市场区隔

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球单细胞分析市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（消耗品、仪器）
  • 依技术（流式细胞仪、次世代定序、PCR、显微镜、质谱、其他技术）
  • 依细胞类型（人类、微生物、动物）
  • 按应用（研究领域、医学领域）
  • 按最终用户（学术和研究实验室、生物技术和製药公司、医院和诊断实验室、细胞库和 IVF 中心）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美单细胞分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲单细胞分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太单细胞分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 南
  • 澳洲

第九章：南美洲单细胞分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲单细胞分析市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific Inc.
• Qiagen NV
• Danaher Corporation
• Becton, Dickinson and Company
• Merck KGaA
• 10X Genomics.
• Takara Bio Inc.
• Standard BioTools Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Single-Cell Analysis Market was valued at USD 3.98 billion in 2024 and is projected to reach USD 7.21 billion by 2030, growing at a CAGR of 10.41%. This market represents the forefront of biomedical innovation, enabling high-resolution interrogation of individual cells across various disciplines including genomics, oncology, immunology, and neurology. Increasing demand for personalized medicine is a major growth driver, as researchers and clinicians employ single-cell technologies to customize treatments for individual patients, enhancing therapeutic efficacy and reducing costs. The ability to characterize tumor heterogeneity at the cellular level has significantly advanced cancer research and diagnostics. Furthermore, innovations such as single-cell RNA sequencing and high-throughput imaging are expanding analytical capabilities, driving adoption in drug development and disease research. As investments surge and applications broaden, single-cell analysis is evolving into a transformative tool across life sciences, accelerating discoveries and fostering precision healthcare advancements globally.

Key Market Drivers

Rising Prevalence of Cancer is Driving the Market

Cancer's global burden continues to rise, with over 19.3 million new cases and 10 million deaths reported in 2020, a figure expected to grow to more than 35 million new cases by 2050. This escalating prevalence is fueling the growth of the single-cell analysis market. Unlike traditional methods, single-cell analysis reveals tumor heterogeneity, allowing for the detection of rare and therapy-resistant cell populations. This capability enhances our understanding of cancer progression and resistance mechanisms. Furthermore, it plays a pivotal role in precision oncology by identifying cell-specific mutations and expression profiles to guide personalized treatment strategies. Through integrative approaches such as single-cell sequencing of genomics, transcriptomics, proteomics, and metabolomics, researchers can deeply probe cancer biology, fostering the development of targeted and effective therapies. As single-cell techniques gain traction in clinical oncology, their application continues to drive the expansion of the market.

Key Market Challenges

Data Complexity and Interpretation

The granularity of single-cell analysis yields massive and complex datasets that are challenging to manage and interpret. Unlike bulk analysis, which provides averaged results across cell populations, single-cell techniques generate data on a per-cell basis, leading to high-dimensional datasets that require advanced storage, processing, and analytical infrastructure. Additionally, the diversity of data types-ranging from scRNA-seq to single-cell proteomics and epigenomics-complicates integration efforts. Extracting actionable insights from this multi-layered information demands sophisticated bioinformatics tools and expert data interpretation, posing a barrier for widespread adoption, particularly in non-specialized research and clinical settings.

Key Market Trends

Multi-Omics Integration

The integration of multiple omics layers-genomics, transcriptomics, proteomics, and metabolomics-at the single-cell level is emerging as a transformative trend in the market. This comprehensive analytical approach enables researchers to construct a holistic understanding of cellular function and disease pathology. By capturing diverse molecular profiles within individual cells, multi-omics integration facilitates the identification of novel biomarkers, mechanisms of disease progression, and therapeutic targets. This capability is accelerating breakthroughs in precision medicine and is being widely adopted in both academic research and pharmaceutical development. As demand grows for deeper biological insights, this trend is expected to significantly enhance the scope and impact of single-cell technologies.

Key Market Players

• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• Danaher Corporation
• Becton, Dickinson and Company.
• Merck KGaA
• 10X Genomics
• Takara Bio Inc.
• Standard BioTools Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.

Report Scope:

In this report, the Global Single Cell Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single Cell Analysis Market, By Product:

• Consumables
• Instruments

Single Cell Analysis Market, By Technique:

• Flow cytometry
• Next Generation Sequencing
• PCR, Microscopy
• Mass Spectrometry
• Other techniques

Single Cell Analysis Market, By Cell Type:

• Human
• Microbial
• Animal

Single Cell Analysis Market, By Application:

• Research Field
• Medical Field

Single Cell Analysis Market, By End User:

• Academic & Research laboratories
• Biotechnology & Pharmaceutical companies
• Hospital & diagnostic laboratories
• Cell banks & IVF Centres

Single Cell Analysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Single Cell Analysis Market.

Available Customizations:

Global Single Cell Analysis market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Single Cell Analysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments)
  • 5.2.2. By Technique (Flow cytometry, Next Generation Sequencing, PCR, Microscopy, Mass Spectrometry, Other techniques)
  • 5.2.3. By Cell Type (Human, Microbial, Animal)
  • 5.2.4. By Application (Research Field, Medical Field)
  • 5.2.5. By End User (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospital & diagnostic laboratories, Cell banks & IVF Centers)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Single Cell Analysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By Cell Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Single Cell Analysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Cell Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Single Cell Analysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Cell Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Single Cell Analysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Cell Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Single Cell Analysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By Cell Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Single Cell Analysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Cell Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Single Cell Analysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Cell Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Single Cell Analysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Cell Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Single Cell Analysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Cell Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Single Cell Analysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Cell Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Single Cell Analysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By Cell Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Single Cell Analysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Cell Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Single Cell Analysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Cell Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Single Cell Analysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Cell Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Single Cell Analysis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Cell Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Single Cell Analysis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Cell Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Single Cell Analysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By Cell Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Single Cell Analysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Cell Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Single Cell Analysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Cell Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Single Cell Analysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Cell Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Single Cell Analysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By Cell Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Single Cell Analysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Cell Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Single Cell Analysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Cell Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Single Cell Analysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Cell Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Qiagen N.V.
• 14.3. Danaher Corporation
• 14.4. Becton, Dickinson and Company
• 14.5. Merck KGaA
• 14.6. 10X Genomics.
• 14.7. Takara Bio Inc.
• 14.8. Standard BioTools Inc.
• 14.9. Bio-Rad Laboratories Inc.
• 14.10. Illumina Inc.

15. Strategic Recommendations

16. About Us & Disclaimer